GEN has retained its position as the number one biotech publisher around the globe since its launch in 1981, with a print edition, additional content online, and a networking platform, GENconnect. Fri, 25 May 2012 07:53:25 -0400 http://www.genengnews.com/media/files/rss/TRANSLATIONAL-MEDICINE-therapeutics.xml http://www.genengnews.com/gen-news-highlights/imi-launches-223-7m-industry-academia-program-to-tackle-antibiotic-resistance/81246816/ http://www.genengnews.com/gen-news-highlights/imi-launches-223-7m-industry-academia-program-to-tackle-antibiotic-resistance/81246816/ Thu, 24 May 2012 08:03:00 -0400 http://www.genengnews.com/gen-news-highlights/immune-pharmaceuticals-yeda-partner-on-her3-antibody-development/81246814/ http://www.genengnews.com/gen-news-highlights/immune-pharmaceuticals-yeda-partner-on-her3-antibody-development/81246814/ Thu, 24 May 2012 07:58:00 -0400 http://www.genengnews.com/gen-news-highlights/fda-clears-novo-nordisk-s-levemir-for-diabetic-children-aged-two-years-and-over/81246813/ http://www.genengnews.com/gen-news-highlights/fda-clears-novo-nordisk-s-levemir-for-diabetic-children-aged-two-years-and-over/81246813/ Thu, 24 May 2012 07:55:00 -0400